0001161697-23-000586.txt : 20231207
0001161697-23-000586.hdr.sgml : 20231207
20231207170014
ACCESSION NUMBER: 0001161697-23-000586
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231205
FILED AS OF DATE: 20231207
DATE AS OF CHANGE: 20231207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Steve
CENTRAL INDEX KEY: 0001402535
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 231473009
MAIL ADDRESS:
STREET 1: 220 MIRACLE MILE
STREET 2: SUITE 234
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 12-05-2023
X0508
4
2023-12-05
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001402535
Miller Steve
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Op. & Scientific Officer
0
Common stock, par value $0.001 per share
2023-12-05
4
S
0
40000
14.24
D
647457
D
Shares were sold to fund the exercise price and tax withholding associated with the exercise of a stock option that will expire on January 3, 2024 and not as a result of any disagreement with the Company.
Represents a weighted average price for the shares sold. Shares were sold in a range from $14.23 to $14.26 per share.
/s/ Steve Miller
2023-12-07